| Particulars |
|
|
|
| Company Name
| Lincoln Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
20.03 |
B.V. (₹) |
335.30 |
| Sales(₹ Cr.) |
623.23 |
NP (₹ Cr.) |
81.03 |
| NP Var (%) |
-12.00 |
Div% |
18.00 |
| CPS(₹) |
46.90 |
EPS (₹) |
40.50 |
| Traded Value(₹ Lakhs) |
12.78 |
52 Week High |
975.00 |
| 52 Week Low |
491.00 |
Price BSE |
525.00 |
| Price NSE |
526.00 |
Market Capital (₹ Cr.) |
1,051.86 |
| P/C Ratio |
11.20 |
P/E Ratio |
13.00 |
| Price Vs.BV |
1.57 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
163.36 |
| NP(₹ Cr.) |
19.98 |
NP Var % |
-24.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
597.44 |
| OPM |
16.60 |
NP |
96.64 |
| NP Var (%) |
-17.21 |
EPS |
43.11 |
| PE |
12.18 |
|
|